South Korea: In a post hoc analysis of the randomized PULSAR trial, aflibercept 8 mg demonstrated noninferior visual outcomes ...
Nemolizumab, which targets the interleukin-31 pathway, rapidly improves itch and sleep in people with atopic dermatitis and ...
On December 24, President Ilham Aliyev and First Lady Mehriban Aliyeva visited several liberated areas, a visit that carried ...
Starting an incretin receptor agonist -- especially tirzepatide (Mounjaro, Zepbound) -- was associated with reduced risks of ...
Phase III OASIS 4 trial showed 16.6% mean weight loss with oral semaglutide, outperforming placebo. The FDA approval of oral semaglutide marks the first GLP-1 pill for chronic weight management, ...
The prospective data indicate that clinicians should be aggressive with lipid-lowering therapies in these patients, experts say.
Nemolizumab rapidly relieves itch and sleep disturbance among patients with moderate-to-severe atopic dermatitis (AD) and ...
Oral micronutrient supplementation showed no benefit on geographic atrophy lesion growth among a patient group from the OAKS and DERBY trials, according to a speaker ...
Abstract: Aiming at the performance analysis of statistical priority-based multiple access (SPMA) protocol, the time slot transmission probability modeling method based on preemptive M/G/1 queue is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback